IL-2 Program with Bonum’s Drs. John Mulligan and Neela Patel Business of Biotech Dec 20, 2023 Podcast
Realizing the Therapeutic Potential of Cytokines by Making them Context Dependent The Bio Report Aug 20, 2023 Podcast
Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics LinkedIn Mar 30, 2023 Blog
Founder & CEO John Mulligan Shares Bonum Therapeutics’ “No Jerks” Approach to Hiring LinkedIn Feb 14, 2023 Blog